Literature DB >> 2665864

Comparison of fractionated to single-dose total body irradiation in conditioning canine littermates for DLA-identical marrow grafts.

R Storb1, R F Raff, F R Appelbaum, T C Graham, F G Schuening, G Sale, M Pepe.   

Abstract

We explored the ability of fractionated total body irradiation (TBI) given at a rate of 7 cGy/min from opposing dual 60Co sources at otherwise lethal doses of 450, 600, 700, 800, and 920 cGy to condition dogs for marrow grafts from DLA-identical littermates. Results were compared with those of a previously reported study using single-dose TBI administered under otherwise identical conditions. Fractionated TBI was less immunosuppressive than single-dose TBI, as evidenced by a significantly higher rate of graft rejection (P = .001). Specifically, sustained allogeneic engraftment was observed in only two of 18 (11%) dogs that received 600 to 800 cGy fractionated TBI as compared with 11 of 17 (65%) dogs that received comparable doses of single-dose TBI. Only at 450 cGy (none of the ten dogs studied had sustained engraftment) and at 920 cGy (four of five dogs that received fractionated and 20 of 21 dogs that received single-dose TBI engrafted) were we unable to find differences between the two modes of radiation. Most dogs that rejected their graft survived with autologous recovery (13 of 22 that received fractionated and eight of 12 that received single-dose TBI; P = .49), presumably the result of extended support provided by the transient allogeneic grafts. We conclude that at equivalent doses fractionated TBI is significantly less effective than single-dose TBI to condition DLA-identical littermate dogs for marrow transplantation. These findings have implications for the design of conditioning programs in clinical transplantation, especially when T-cell-depleted marrow grafts are used.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2665864

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

Review 1.  Increased intensity lymphodepletion and adoptive immunotherapy--how far can we go?

Authors:  Pawel Muranski; Andrea Boni; Claudia Wrzesinski; Deborah E Citrin; Steven A Rosenberg; Richard Childs; Nicholas P Restifo
Journal:  Nat Clin Pract Oncol       Date:  2006-12

2.  A preclinical model of double- versus single-unit unrelated cord blood transplantation.

Authors:  George E Georges; Vladimir Lesnikov; Szczepan W Baran; Anna Aragon; Marina Lesnikova; Robert Jordan; Ya-Ju Laura Yang; Murad Y Yunusov; Eustacia Zellmer; Shelly Heimfeld; Gopalakrishnan M Venkataraman; Michael A Harkey; Scott S Graves; Rainer Storb; Barry E Storer; Richard A Nash
Journal:  Biol Blood Marrow Transplant       Date:  2010-03-18       Impact factor: 5.742

Review 3.  Mouse models in bone marrow transplantation and adoptive cellular therapy.

Authors:  Caroline Arber; Malcolm K Brenner; Pavan Reddy
Journal:  Semin Hematol       Date:  2013-06-11       Impact factor: 3.851

4.  Five decades of progress in haematopoietic cell transplantation based on the preclinical canine model.

Authors:  M Lupu; R Storb
Journal:  Vet Comp Oncol       Date:  2007-03       Impact factor: 2.613

5.  Fludarabine and 2-Gy TBI is superior to 2 Gy TBI as conditioning for HLA-matched related hematopoietic cell transplantation: a phase III randomized trial.

Authors:  Brian Kornblit; David G Maloney; Rainer Storb; Jan Storek; Parameswaran Hari; Vladan Vucinic; Richard T Maziarz; Thomas R Chauncey; Michael A Pulsipher; Benedetto Bruno; Finn B Petersen; Wolfgang A Bethge; Kai Hübel; Michelle E Bouvier; Takahiro Fukuda; Barry E Storer; Brenda M Sandmaier
Journal:  Biol Blood Marrow Transplant       Date:  2013-06-11       Impact factor: 5.742

6.  Delaying DLA-haploidentical hematopoietic cell transplantation after total body irradiation.

Authors:  Yunchuan Ding; Marcello Rotta; Scott S Graves; Barry E Storer; Laura J Peterson; George E Sale; Reza Forough; Eustacia Zellmer; George E Georges; Brenda M Sandmaier; Christian S Kuhr; Rainer Storb
Journal:  Biol Blood Marrow Transplant       Date:  2009-08-03       Impact factor: 5.742

7.  Total body irradiation dose escalation decreases risk of progression and graft rejection after hematopoietic cell transplantation for myelodysplastic syndromes or myeloproliferative neoplasms.

Authors:  Federico Monaco; Bart L Scott; Thomas R Chauncey; Finn B Petersen; Barry E Storer; Frederic Baron; Mary E Flowers; H Joachim Deeg; David G Maloney; Rainer Storb; Brenda M Sandmaier
Journal:  Haematologica       Date:  2019-01-10       Impact factor: 9.941

8.  What role is there for antithymocyte globulin in allogeneic nonmyeloablative canine hematopoietic cell transplantation?

Authors:  Razvan Diaconescu; Marie-Térèse Little; Wendy Leisenring; Murad Yunusov; William J Hogan; Mohamed L Sorror; Frédéric Baron; Rainer Storb
Journal:  Biol Blood Marrow Transplant       Date:  2005-05       Impact factor: 5.742

Review 9.  Evolution of haematopoietic cell transplantation for canine blood disorders and a platform for solid organ transplantation.

Authors:  Scott S Graves; Rainer Storb
Journal:  Vet Med Sci       Date:  2021-08-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.